Richard Spector
Corporate Officer/Principal chez FEMASYS INC.
Fortune : - $ au 31/05/2024
Postes actifs de Richard Spector
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FEMASYS INC. | Corporate Officer/Principal | 01/02/2024 | - |
Historique de carrière de Richard Spector
Anciens postes connus de Richard Spector
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INSULET CORPORATION | Corporate Officer/Principal | - | - |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Sales & Marketing | - | - |
QLibrium, Inc.
 QLibrium, Inc. Medical DistributorsDistribution Services QLibrium, Inc. distributes on-body drug delivery systems. The private company is located in the US. | Corporate Officer/Principal | - | - |
Formation de Richard Spector
| The California State University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Sales & Marketing | 1 |
Sectorielle
| Health Technology | 3 |
| Electronic Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FEMASYS INC. | Electronic Technology |
| INSULET CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
QLibrium, Inc.
QLibrium, Inc. Medical DistributorsDistribution Services QLibrium, Inc. distributes on-body drug delivery systems. The private company is located in the US. | Distribution Services |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Richard Spector
- Expérience
